0
2021
Prime Editing And Crispr Market

Prime Editing and CRISPR Market

by Service (Cell Line Engineering, Genome Regulation, Gene Editing, and Gene-Modified Cell Therapy), Application (Biomedical Research & Therapy, Agricultural Research, and Others), and End User (Academic Institutes, Biotechnology & Pharma Companies, and Contract Research Organizations): Global Opportunity Analysis and Industry Forecast, 2021--2030

Report Code: A11781
Pages: 271
Jun 2021 | 2524 Views
Author(s) : Linu D , Onkar S
Tables: 119
Charts: 31
  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Prime Editing And Crispr Market

Request Now !

The global prime editing and CRISPR market was valued at $2,694.2 million in 2020, and is estimated to reach $23,493.0 million by 2030, growing at a CAGR of 24.3% from 2021 to 2030.

The COVID-19 outbreak is anticipated to have a positive impact on growth of the global digital health market. The COVID-19 pandemic has stressed health care system in the world and increased the need for development of healthcare information technology, and remote monitoring services.

Prime editing and CRISPR is a genome editing technology in which the genome of living organism is modified by search and replace technique. Prime editing is composed of two components, namely, engineered prime editing guide RNA (pregRNA) and a prime editor (PE). It includes different genetic engineering tools and techniques for alteration of a particular DNA sequence.

Global-Prime-Editing-and-CRISPR-Market

Growth of the global prime editing and CRISPR market is majorly driven by increase in demand for targeted gene manipulation technology; rise in funding from private & government organizations for genomic projects; rise in prevalence of genetic-based diseases; and increase in investments in R&D activities by various healthcare companies. According to medical life science, in March 2021, researchers in Medical College of Georgia in U.S. announced that prime editing expand the genetic toolbox to develop disease animal model and correct genetic problems. Moreover, in January 2020, Department of biotechnology, in India, initiated the Genome India Project (GIP) which aims to collect 10,000 genetic samples from citizens and develop a reference genome. Furthermore, according to the CRISPR Medicine, in 2020, it was announced that prime editing also restored function of genetic defect in patient derived organoids. Prime editing and CRISPR emerging technology is also used in cancer biologic study. Surge in demand for genetically modified crops boosts growth of the market. According to the American Association for the Advancement of Science (AAAS), in 2021, it was reported that researchers in the Chinese Academy of Sciences University in China enhance efficiency of plant gene editing with optimized pegRNA designs.

However, side effects associated with prime editing and CRISPR such as legal and ethical issues of and lack of safety in gene editing are expected to restrict the market growth during the forecast period.

Prime Editing And Crispr Market Segmentation

The prime editing and CRISPR market is segmented on the basis of service, application, end user, and region. By services, the market is categorized into cell line engineering, genome regulation, gene editing, and gene-modified cell therapy. By application, it is divided into biomedical research & therapy, agricultural research, and others. By end user, the market is divided into academic institutes, biotechnology & pharma companies, and contract research organizations. 

Prime Editing and CRISPR Market
By Services

Your browser does not support the canvas element.

Gene Editing segment held a dominant position in 2020 and would continue to maintain the lead over the forecast period.

Get more information on this report : Request Sample Pages

Region wise, the market is analyzed across North America (the U.S., Canada and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).

Segment review

Depending on service, the gene editing segment dominated the market in 2020, and is expected to continue this trend throughout the forecast period, owing to increase in demand for gene editing in targeted drug discovery process and advancements in research for genomic-based diseases. However, the gene modified cell therapy segment is expected to witness considerable market growth during the forecast period, owing to increase in prevalence of chronic diseases, surge in demand for stem cell research activities, and increase in demand for genomic models.

Prime Editing and CRISPR Market
By Application

Your browser does not support the canvas element.

Agriculture Research segment is projected as one of the most lucrative segment.

Get more information on this report : Request Sample Pages

On the basis of application, the agriculture research segment dominated the market in 2020, and is expected to continue this trend throughout the forecast period, owing to surge in demand for genetically mutated crops and increase in funding for plant biotechnology by private and government organizations. However, the biomedical research & therapy segment is expected to witness considerable market growth during the forecast period, owing to increase in prevalence of sickle cell anemia, advancements in R&D in the healthcare sector, and surge in adoption of gene editing.

On the basis of end user, the biotechnology & pharma companies segment dominated the market in 2020, and is expected to continue this trend throughout the forecast period, owing to increase in prevalence of chronic and genetic diseases, surge in demand for monoclonal antibodies, vaccines, and use of innovative technology in genetic engineering. However, the academic institution segment is expected to witness considerable market growth during the forecast period, owing to development in research in universities and rise in technological advancements in molecular genetics.

Prime Editing and CRISPR Market
By End User

Your browser does not support the canvas element.

Biotechnology & pharma companies segment is projected as one of the most lucrative segment.

Get more information on this report : Request Sample Pages

North America accounted for a major share in the prime editing and CRISPR market in 2020, and is expected to maintain its dominance during the forecast period, owing to rise in prevalence of genetic diseases, presence of key players, and advancements in R&D in genetic engineering. However, Asia-Pacific is expected to register highest CAGR of 28.1% from 2021 to 2030, owing to increase in prevalence of chronic diseases, rise in geriatric population, increase in demand for novel drugs, and rise in number of laboratories for research.

Key players operating in the global market include Beam Therapeutics, CRISPR Therapeutics, GenScript Biotech, Horizon Discovery, Integrated DNA Technologies (IDT), Intellia Therapeutics Inc., Inscripta, Precision Bioscience, Sangoma Therapeutics, and Synthego Corporation.

Prime Editing and CRISPR Market
By Region

2030
North America 
Europe
Asia-Pacific
LAMEA

North America was holding a dominant position in 2020 and would continue to maintain the lead over the analysis period.

Get more information on this report : Request Sample Pages

Key Benefits For Stakeholders

  • The study provides an in-depth analysis of the prime editing and CRISPR market, and the current trends and future estimations to elucidate imminent investment pockets
  • It presents a quantitative analysis of the prime editing and CRISPR market from 2021 to 2030 to enable stakeholders to capitalize on the prevailing market opportunities
  • Extensive analysis of the prime editing and CRISPR market based on procedures and services assists to understand the trends in the industry
  • Key players and their strategies are thoroughly analyzed to understand the competitive outlook of the prime editing and CRISPR market

Key Market Segments

By Service

  • Cell Line Engineering
  • Genome Regulation
  • Gene Editing
  • Gene-Modified Cell Therapy

By Application

  • Biomedical Research & Therapy
  • Agricultural Research
  • Others

By End User

  • Academic Institutes
  • Biomedical Research & Therapy
  • Agricultural Research
  • Others
  • Biotechnology & Pharma Companies
  • Biomedical Research & Therapy
  • Agricultural Research
  • Others
  • Contract Research Organizations
  • Biomedical Research & Therapy
  • Agricultural Research
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players 

  • Beam Therapeutics
  • CRISPR Therapeutics
  • GenScript Biotech
  • Horizon Discovery
  • Integrated DNA Technologies (IDT
  • Intellia Therapeutics Inc.,
  • Inscripta
  • Precision Bioscience
  • Sangoma Therapeutics
  • Synthego Corporation

Prime Editing and CRISPR Market Report Highlights

Aspects Details
By Service
  • Cell Line Engineering
  • Genome Regulation
  • Gene Editing
  • Gene-Modified Cell Therapy
By Application
  • Biomedical Research & Therapy
  • Agricultural Research
  • Others
By End User
  • Academic Institutes
  • .Biomedical Research & Therapy
  • Contract Research Organizations
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Russia, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Thailand, Malaysia, Indonesia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, UAE, Argentina, Rest of LAMEA)
Key Market Players Sangamo Therapeutics., Synthego Corporation., Intellia Therapeutics, Inc., Inscripta, Inc, Genscript Biotech Corporation., Horizon Discovery, Ltd., Precision Biosciences, CRISPR Therapeutics AG., Beam Therapeutics Inc, Integrated DNA Technologies (IDT).
 

Loading Table Of Content...


 
 

According to analyst perspective, growth of the prime editing and CRISPR market is attributed to factors such as technological advancements in R&D for genetics; rise in prevalence of chronic and genetic diseases such as sickle cell anemia, cystic fibrosis, disease due to point mutation, and lung cancer; increase in funds from private and government organizations for genetic research, and surge in demand for monoclonal antibodies and vaccines. The prime editing and CRISPR market gains interest of biotechnology & pharma companies, owing to surge in demand for vaccine and regenerative medicine. This leads to increase in adoption of genetic engineering. Moreover, the market has gained high traction in laboratories and universities in recent years as these tools are used in gene editing.

Further, North America is expected to witness highest growth, in terms of revenue, owing to rise in prevalence of genetic diseases, presence of key players, and advancements in R&D in genetic engineering.

Asia-Pacific was the second-largest contributor to the market in 2020, and is expected to register fastest CAGR during the forecast period, owing to increase in prevalence of chronic diseases, rise in geriatric population, increase in demand for novel drugs, and rise in number of laboratories for research.

In addition, lack of safety and legal ethical issues related to gene editing in human germ line is anticipated to restrain the market growth during the forecast period.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com
 
FREQUENTLY ASKED QUESTIONS?

A. The total market value of prime editing and CRISPR Market is $2,694.2 million in 2020.

A. The forecast period in the report is from 2021 to 2030

A. The market value of prime editing and CRISPR Market in 2021 was $3,327.3 Million

A. Yes, prime editing and CRISPR companies are profiled in the report

A. The top companies that hold the market share in prime editing and CRISPR Market are Beam Therapeutics, CRISPR Therapeutics, GenScript Biotech, Horizon Discovery, Integrated DNA Technologies (IDT), Intellia Therapeutics Inc., Inscripta, Precision Bioscience, Sangoma Therapeutics, Synthego Corporation.

A. No, there is no value chain analysis provided in the prime editing and CRISPR Market report

A. The key trends in the prime editing and CRISPR Market are rise in R&D in genetic engineering, increase in prevalence of genetic based disease, and surge in demand for genetically modified crops

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Request Free Sample
RELATED TAGS

Purchase Full Report of
Prime Editing And Crispr Market

Start reading instantly.
This Report and over 53,662+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,712
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
    (Jun 2022 - Jun 2023)
  • Data Pack
  • $4,125
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Jun 2022 - Jun 2023)
  • Single User
  • $5,769
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Jun 2022 - Jun 2023)
  • Five Users
  • $6,929
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Jun 2022 - Jun 2023)
  • Enterprise
    License/PDF

  • $10,663
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Jun 2022 - Jun 2023)
  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers